Core Insights - Quest Diagnostics has announced a collaboration with Google Cloud to enhance data management, analytics, and patient experiences through advanced technologies [1][2][3] Company Strategy - The collaboration will utilize Google Cloud's generative AI and data analytics technologies, including Google Agentspace, to automate tasks and improve operations across various areas such as R&D and customer experience [2][4] - Quest aims to streamline its systems to enhance data quality, management, and security, while also exploring the use of generative AI to improve patient engagement and empower physicians with insights [3][4] Industry Impact - This partnership is significant as it marks one of the first instances of a national laboratory provider leveraging generative AI across multiple operational areas, indicating a shift towards more personalized and proactive healthcare solutions [2][4] - The collaboration is expected to strengthen Quest's hybrid cloud strategy, enhancing its data and AI capabilities while ensuring compliance with HIPAA regulations for data privacy and security [4][5] Performance Metrics - In 2024, Quest Diagnostics processed over 200 million test requisitions and managed more than 80 billion datapoints, showcasing its extensive operational scale [4]

Quest Diagnostics (DGX) has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain.Presently carrying a Zacks Rank #3 (Hold), the renowned clinical laboratory continues to demonstrate robust momentum in its core customer channel, supported by a growing utilization of the Advanced Diagnostics portfolio. Strategic outreach acquisitions and a strong focus on driving operational improvements further bode well ...

Quest Diagnostics Inc. (DGX) benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight transactions in 2024. A strong focus on operational excellence is highly encouraging for the stock. Meanwhile, the adverse impacts of the broader industry challenges and fierce competitive landscape pose risks to its operations.In the past year, this Zacks Rank #3 (Hold) stock has rallied 38% compared with the industry’s ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number 001-12215 Quest Diagnostics Incorporated 500 Plaza Drive Secaucus, NJ 07094 (973) 520-2700 Delaware 16-1387862 ...

SECAUCUS, N.J., Feb. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, March 19, 2025 at the New York Stock Exchange. During the event, Jim Davis, Chairman, CEO and President, Sam Samad, Executive Vice President and CFO, and other senior executives will provide updated views of the U.S. laboratory market, and the company's business strategy, ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style S ...

Quest Diagnostics (DGX) is gaining from advanced diagnostics offerings and strategic acquisitions. Rising debts and industry challenges continue to dent growth. The stock carries a Zacks Rank #3 (Hold).Factors Driving DGX StockQuest Diagnostics’ growth in the Physician Lab Services is backed by new customer wins, growing utilization of the company’s Advanced Diagnostics portfolio and contributions from acquisitions. The ongoing strength in healthcare utilization boosted growth throughout 2024. Quest Diagnos ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

SECAUCUS, N.J., Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, s ...